These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 35155187)
1. Ethyl Ferulate Suppresses Esophageal Squamous Cell Carcinoma Tumor Growth Through Inhibiting the mTOR Signaling Pathway. Pang M; Xie X; Zhang Y; Laster KV; Liu K; Kim DJ Front Oncol; 2021; 11():780011. PubMed ID: 35155187 [TBL] [Abstract][Full Text] [Related]
2. Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR Shi X; Zhang Y; Xie X; Pang M; Laster K; Li J; Ma X; Liu K; Dong Z; Kim DJ Front Oncol; 2021; 11():648809. PubMed ID: 34178634 [TBL] [Abstract][Full Text] [Related]
3. Harmaline isolated from Peganum harmala suppresses growth of esophageal squamous cell carcinoma through targeting mTOR. Zhang Y; Shi X; Xie X; Laster KV; Pang M; Liu K; Hwang J; Kim DJ Phytother Res; 2021 Nov; 35(11):6377-6388. PubMed ID: 34545650 [TBL] [Abstract][Full Text] [Related]
4. Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma. Liu F; Zu X; Xie X; Zhang Y; Liu K; Chen H; Wang T; Bode AM; Dong Z; Kim DJ Cancer Prev Res (Phila); 2019 Dec; 12(12):849-860. PubMed ID: 31554627 [TBL] [Abstract][Full Text] [Related]
5. Omipalisib Inhibits Esophageal Squamous Cell Carcinoma Growth Through Inactivation of Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) and ERK Signaling. Zhu DS; Dong JY; Xu YY; Zhang XT; Fu SB; Liu W Med Sci Monit; 2020 Aug; 26():e927106. PubMed ID: 32804918 [TBL] [Abstract][Full Text] [Related]
6. 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo. Zu X; Ma X; Xie X; Lu B; Laster K; Liu K; Dong Z; Kim DJ J Exp Clin Cancer Res; 2020 Jun; 39(1):107. PubMed ID: 32517736 [TBL] [Abstract][Full Text] [Related]
7. Protein Arginine Methyltransferase 5 Promotes Esophageal Squamous Cell Carcinoma Proliferation and Metastasis via LKB1/AMPK/mTOR Signaling Pathway. Chen YR; Li HN; Zhang LJ; Zhang C; He JG Front Bioeng Biotechnol; 2021; 9():645375. PubMed ID: 34124017 [No Abstract] [Full Text] [Related]
8. Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma. Liu TT; Yang KX; Yu J; Cao YY; Ren JS; Hao JJ; Pan BQ; Ma S; Yang LY; Cai Y; Wang MR; Zhang Y J Mol Med (Berl); 2018 Aug; 96(8):807-817. PubMed ID: 29959473 [TBL] [Abstract][Full Text] [Related]
9. Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma. Li SH; Chen CH; Lu HI; Huang WT; Tien WY; Lan YC; Lee CC; Chen YH; Huang HY; Chang AY; Lin WC Surgery; 2015 Mar; 157(3):570-80. PubMed ID: 25726316 [TBL] [Abstract][Full Text] [Related]
10. Chloride intracellular channel 1 promotes esophageal squamous cell carcinoma proliferation via mTOR signalling. Geng H; Feng C; Sun Z; Fan X; Xie Y; Gu J; Fan L; Liu G; Li C; Thorne RF; Zhang XD; Li X; Liu X Transl Oncol; 2023 Jan; 27():101560. PubMed ID: 36252281 [TBL] [Abstract][Full Text] [Related]
11. Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo. Li H; Juan L; Xia L; Wang Y; Bao Y; Sun G Med Sci Monit; 2016 Jul; 22():2624-34. PubMed ID: 27453171 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma. He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034 [TBL] [Abstract][Full Text] [Related]
13. Dihydroartemisinin Inhibits the Proliferation of Esophageal Squamous Cell Carcinoma Partially by Targeting AKT1 and p70S6K. Zhu L; Chen X; Zhu Y; Qin J; Niu T; Ding Y; Xiao Y; Jiang Y; Liu K; Lu J; Yang W; Qiao Y; Jin G; Ma J; Dong Z; Zhao J Front Pharmacol; 2020; 11():587470. PubMed ID: 33658929 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation. Li SH; Lu HI; Chang AY; Huang WT; Lin WC; Lee CC; Tien WY; Lan YC; Tsai HT; Chen CH Oncotarget; 2016 Oct; 7(41):67150-67165. PubMed ID: 27564102 [TBL] [Abstract][Full Text] [Related]
15. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest. Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693 [TBL] [Abstract][Full Text] [Related]
16. Histone deacetylases inhibitor MS-275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway. Ma S; Liu T; Xu L; Wang Y; Zhou J; Huang T; Li P; Liu H; Zhang Y; Zhou X; Cui Y; Zang X; Wang Y; Guan F J Cell Physiol; 2019 Dec; 234(12):22400-22410. PubMed ID: 31120582 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma. Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206 [TBL] [Abstract][Full Text] [Related]
19. Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo. Xie X; Zu X; Liu F; Wang T; Wang X; Chen H; Liu K; Wang P; Liu F; Zheng Y; Bode AM; Dong Z; Kim DJ Mol Carcinog; 2019 Jul; 58(7):1248-1259. PubMed ID: 31100197 [TBL] [Abstract][Full Text] [Related]
20. Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway. Fan H; Yu X; Zou Z; Zheng W; Deng X; Guo L; Jiang W; Zhan Q; Lu SH Carcinogenesis; 2019 Jul; 40(5):669-679. PubMed ID: 30445633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]